A Prospective Trial Of Oral Lead Chelation To Slow Renal Function Decline In Lead-Loaded Type 2 Diabetic Nephropathy Patients

NCT07709871 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetic Nephropathy With Elevated Blood Lead Burden

Interventions

DRUG: Dimercaptosuccinic acid oral chelation therapy

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine